That may be so here, but not necessarily in the markets that Betadine operates in. Australian sensibilities are different and aesthetics differ from region to region, culture to culture. I'm sure Aspen will reflect the Australian market, and Betadine know their market, will do their research and market the product accordingly.
- Forums
- ASX - By Stock
- SPL
- Ann: Mundipharma licenses Starpharma's VivaGel BV
Ann: Mundipharma licenses Starpharma's VivaGel BV, page-42
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.1¢ |
Change
0.001(1.11%) |
Mkt cap ! $38.04M |
Open | High | Low | Value | Volume |
9.0¢ | 9.2¢ | 9.0¢ | $39.18K | 430.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 93259 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 6900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 93259 | 0.091 |
3 | 333792 | 0.090 |
2 | 120350 | 0.089 |
3 | 628000 | 0.088 |
2 | 130726 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 6900 | 1 |
0.094 | 69440 | 2 |
0.095 | 186529 | 5 |
0.096 | 104177 | 1 |
0.099 | 50000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |